Literature DB >> 20371740

Endothelin type A receptor (ETA) expression is regulated by HOXA10 in human endometrial stromal cells.

Ivan A Penna1, Amanda N Kallen, Hugh S Taylor.   

Abstract

Endothelin type A receptor (ET(A)) is a member of the superfamily of G protein-coupled receptors. Our laboratory conducted a microarray screen that identified ET(A) as target of HOXA10 transcriptional control in endometrium. Here, we confirm HOXA10-regulated ET(A) expression in endometrium. Endometrial biopsies were obtained from fertile reproductive-age individuals, and first trimester decidual samples were obtained at the time of elective termination. Immunohistochemistry (IHC) was used to identify ET(A) protein in endometrium as well as first trimester decidua. ET(A) was expressed in endometrial stromal cells throughout the menstrual cycle. ET(A) was also highly expressed in first trimester decidual cells. The regulatory relationship between HOXA10 and ET(A) was established by transient transfection analysis. The human endometrial stromal cell line (HESC) and the human endometrial epithelial cell line (Ishikawa) were transfected with pcDNA/HOXA10, HOXA10 small interfering RNA (siRNA), or respective controls. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was performed to determine expression levels of HOXA10 and ET(A) in each group. ET(A) gene expression increased 9-fold (P < .05) after pcDNA/HOXA10 transfection of HESC. ET(A) was not regulated by HOXA10 in Ishikawa cells. We conclude that ET(A) is expressed in normal endometrium and decidua. Expression of this receptor is regulated by an essential mediator of endometrial receptivity, HOXA10. ET(A) may enhance the proliferative potential of endometrial cells in a manner similar to that seen in vascular smooth muscle cells. ET( A) likely acts as a molecular mechanism by which HOXA10 promotes stromal cell growth and prostaglandin production in both the implantation window and decidua.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371740      PMCID: PMC3107845          DOI: 10.1177/1933719110361961

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  34 in total

Review 1.  Current concepts of the mechanisms of menstruation.

Authors:  L A Salamonsen; G T Kovacs; J K Findlay
Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol       Date:  1999-06

2.  Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells.

Authors:  Gaurang S Daftary; Patrick J Troy; Catherine N Bagot; Steven L Young; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2002-03

3.  Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10.

Authors:  Patrick J Troy; Gaurang S Daftary; Catherine N Bagot; Hugh S Taylor
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system.

Authors:  K Block; A Kardana; P Igarashi; H S Taylor
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

5.  Pleiotropic effects of Hoxa10 on the functional development of peri-implantation endometrium.

Authors:  Gaurang S Daftary; Hugh S Taylor
Journal:  Mol Reprod Dev       Date:  2004-01       Impact factor: 2.609

6.  Gene expression of endothelin-1 in the porcine ovary: follicular development.

Authors:  J A Flores; H M Sasway
Journal:  Biol Reprod       Date:  2000-11       Impact factor: 4.285

7.  Endothelin-1 mediates prostaglandin F(2alpha)-induced luteal regression in the ewe.

Authors:  S T Hinckley; R A Milvae
Journal:  Biol Reprod       Date:  2001-06       Impact factor: 4.285

8.  Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation.

Authors:  C N Bagot; P J Troy; H S Taylor
Journal:  Gene Ther       Date:  2000-08       Impact factor: 5.250

Review 9.  Endothelin-1 receptors and biosynthesis in the corpus luteum: molecular and physiological implications.

Authors:  Rina Meidan; Nitzan Levy
Journal:  Domest Anim Endocrinol       Date:  2002-07       Impact factor: 2.290

10.  Historical review: Endothelin.

Authors:  Tomoh Masaki
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

View more
  2 in total

1.  Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.

Authors:  Sharif Sakr; Hanyia Naqvi; Barry Komm; Hugh S Taylor
Journal:  Endocrinology       Date:  2014-01-31       Impact factor: 4.736

2.  Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.

Authors:  Jaime Kulak; Catha Fischer; Barry Komm; Hugh S Taylor
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.